(THIS WEBSITE IS  SUBJECT TO CHANGES, PLEASE CHECK THE CONGRESS APP AS WELL FOR UPDATED INFORMATION)
  
PLEASE FIND BELOW THE PROGRAMME
Please note that:
  • the sessions are not ordered in the same way as the programme
  • posters are on display in the poster area for four days and will be open for viewing during exhibition hours
For the complete overview of the programme please go to the scientific programme on the congress website: http://www.fip.org/pswc2014/Melbourne/2041/Programme/
 
 
Scientific Programme
 
 
Sunday, 13 April 2014
Monday, 14 April 2014
Tuesday, 15 April 2014
Wednesday, 16 April 2014
POSTER SESSIONS
BIOGRAPHIES INVITED SPEAKERS
 
 
Sunday, 13 April 2014
 
09:00-12:30 Meeting Room 207
WORKSHOP 1: BIOSIMILAR MONOCLONAL ANTIBODIES
Chair:  O'Connor, A. (Hoffman, United States of America)
 
09:00-12:30  
WORKSHOP 2: CHALLENGES OF POORLY WATER SOLUBLE DRUGS
Chair:  Porter, C. (Melbourne, Australia)
 
09:00-12:30 Meeting Room 209
WORKSHOP 3: TRANSLATIONAL MODELLING
Chair:  Kirkpatrick (Melbourne, Australia)
 
09:00-12:30 Meeting Room 218
WORKSHOP 4: TRANSPORTERS IN DRUG DISPOSITION
Chair:  Nicolazzo, J. (Parkville, Australia)
 
15:00-17:00  
FIP OPENING PLENARY CEREMONY
 
Monday, 14 April 2014
 
08:00-19:00 Plenary 3
PHARMACEUTICAL SCIENCES 2020: AN AMERICAN PERSPECTIVE
Chair:  Tucker, G. (Sheffield, United Kingdom) ; Giuliani (Bologna, Italy)
 
09:00-10:00 Plenary 3
KEYNOTE: RE-INVENTING CLINICAL DRUG DEVELOPMENT:IT’S ALL ABOUT THE PHARMACEUTICAL SCIENCE!
Chair:  Charman, S. (Parkville, Australia) ; Lee, K. (, Australia)
 
09:00-10:00 Meeting Room 212 & 213
FIP-ED KEYNOTE
Chair:  Marriot, J. (, Australia) ; Cheah, J. (, Australia)
 
09:00-10:00 Meeting Room 219 & 220
MINI-SYMPOSIUM: PK-PD TO ENHANCE MODEL-BASED DRUG DEVELOPMENT
Chair:  Reuter, E. (Adelaide, Australia)
 
09:00-10:00 Meeting Room 210
MINI-SYMPOSIUM: CHALLENGES IN BIOEQUIVALENCE FOR INHALED PRODUCTS
Chair:  Shah (North Potomac Md, United States of America)
 
09:00-10:00 Meeting Room 211
BPS / BPP PLENARY
Chair:  Maitland van der Zee, A.H. (, The Netherlands)
 
10:30-12:00 Plenary 3
SYMPOSIUM: EMERGING MARKETS/EAST MEETS WEST
Chair:  Rayner, C. (, Australia)
 
10:30-12:00 Meeting Room 212 & 213
SYMPOSIUM: DOUWE BREIMER FOUNDATION SYMPOSIUM
Chair:  Breimer, D. (, The Netherlands)
 
10:30-12:00 Meeting Room 219 & 220
SYMPOSIUM: PK-PD FOR SUPPORTING CLINICAL DECISIONS AND POINT-OF-CARE DOSAGE
Chair:  Kirkpatrick (Melbourne, Australia)
 
10:30-12:00 Meeting Room 210
SYMPOSIUM: CHALLENGES FOR THE DEVELOPMENT OF DRUGS WITH LOW AQUEOUS SOLUBILITY AND/OR LOW PERMEABILITY
Chair:  Stella, V.J. (Lawrence Ks, United States of America)
 
10:30-12:00 Meeting Room 211
SYMPOSIUM: PHARMACOEPIDEMIOLOGY: BRIDGING PHARMACEUTICAL SCIENCE AND PRACTICE
Chair:  Sansom, L. (Adelaide, Australia)
 
13:00-14:00 Plenary 3
FIP KEYNOTE: BEYOND COST ARBITRAGE: GLOBALLY NETWORKED POLYCENTRIC R&D ADDRESSING AFFORDABILITY AND ACCESSIBILITY
Chair:  Midha, K. (, India)
 
13:00-14:00 Meeting Room 212 & 213
FIP KEYNOTE: DRUG DELIVERY TO THE BRAIN: IS THE BLOOD-BRAIN BARRIER A FRIEND OR FOE?
Chair:  Nicolazzo, J. (Parkville, Australia)
 
13:00-14:30 Meeting Room 219 & 220
SUBMITTED ORALS
Chair:  Tucker, I. (Dunedin, New Zealand)
 
13:00-14:30 Meeting Room 210
SYMPOSIUM: GENE-BASED THERAPEUTICS: POSSIBILITIES AND CHALLENGES
Chair:  Pouton (Parkville, Australia)
 
13:00-14:00 Meeting Room 211
PLENARY: MEDICATION SAFETY: CHALLENGES FOR THE 21ST CENTURY
Chair:  Kelly, L. (, Australia)
 
14:00-15:30 Plenary 3
SUBMITTED ORALS
Chair:  Semple, S. (Adelaide, Australia)
 
14:00-15:30 Meeting Room 212 & 213
SUBMITTED ORALS
Chair:  Kumamoto, T. (Nihitokyo Tokyo, Japan)
 
14:00-15:30 Meeting Room 211
SUBMITTED ORALS
Chair:  Peterson (Hobart, Australia)
 
14:30-15:30 Meeting Room 219 & 220
FIP KEYNOTE: REGULATORS, PAYERS AND INDUSTRY – CONVERGENCE OR DIVERGENCE
Chair:  Skerritt, J. (, Australia)
 
14:30-15:30 Meeting Room 210
FIP KEYNOTE: COMPARING NANOPARTICLE AND CLASSIC MICROPARTICLE IN VIVO FATES
Chair:  Morris, Marilyn (, Australia)
 
16:00-17:30 Plenary 3
SUBMITTED ORAL
Chair:  Bergstrom, C.A.S. (Uppsala, Sweden)
 
16:00-17:20 Meeting Room 212 & 213
SINGAPORE SHOWCASE
Chair:  Chui (Singapore, Singapore)
 
16:00-17:30 Meeting Room 219 & 220
MODERATED DEBATE: CARRIER MEDIATED TRANSPORT THROUGH MEMBRANES: THE EXCEPTION OR THE RULE?
Chair:  Pauletti (Cincinnati, United States of America)
 
16:00-17:30 Meeting Room 210
ROUND TABLE: THE ROLE OF BIOPHARMACEUTICAL TOOLS IN QUALITY BY DESIGN
Chair:  Dressman, J. (Frankfurt Am Main, Germany)
 
16:00-17:30 Meeting Room 211
AUSTRALIAN SHOWCASE: DRUG DISCOVERY AND DEVELOPMENT IN AUSTRALIA
Chair:  Charman, W.N. (Melbourne, Australia)
 
17:30-18:30 Meeting Room 211
PUBLIC LECTURE: SNAKES, SPIDERS AND OTHER VENOMOUS PREDATORS
Chair:  Norton, R. (Melbourne, Australia)
 
Tuesday, 15 April 2014
 
07:00-08:00 Meeting Room 219 & 220
SUNRISE SESSION: MEET THE EXPERT
Chair:  Mager, D. (New York, United States of America) ; Robinson (Melbourne, Australia)
 
07:00-08:00 Meeting Room 210
SUNRISE SESSION: MEET THE EXPERT
Chair:  Sasaki, H. (Nagasaki, Japan) ; Mangal (Melbourne, Australia)
 
07:00-08:00  
Sunrise Session: Meet the Expert
Chair:  Kumamoto, T. (Nihitokyo Tokyo, Japan) ; Lee, G. (Melbourne, Australia)
 
08:00-09:00 Plenary 3
PHARMACEUTICAL SCIENCES 2020: A EUROPEAN PERSPECTIVE
Chair:  Charman, W.N. (Melbourne, Australia) ; Chekhtman, I. (, Australia)
 
09:00-10:00 Plenary 3
FIP KEYNOTE: THE FUTURE OF VACCINES
Chair:  Pouton, C. (Parkville, Australia)
 
09:00-10:00 Meeting Room 212 & 213
MINI-SYMPOSIUM: EVOLUTION OF THE BIOSIMILAR REGULATORY LANDSCAPE – CHALLENGES AND OPPORTUNITIES
Chair:  O'Connor, A. (Hoffman, United States of America)
 
09:00-10:00 Meeting Room 219 & 220
APSA KEYNOTE
Chair:  Aslani, P. (, Australia)
 
09:00-10:00 Meeting Room 210
MINI SYMPOSIUM: NOVEL NANOMATERIALS WITH DRUG DELIVERY APPLICATIONS
Chair:  Prestidge, C. (Adelaide, Australia)
 
09:00-10:00 Meeting Room 211
MINI SYMPOSIUM: PERSONALIZED MEDICINE IN THE CLINIC: READY FOR PRIMETIME?
Chair:  Sorich, M. (Adelaide, Australia)
 
10:30-12:00 Plenary 3
SYMPOSIUM: ACADEMIA AND PHARMA COLLABORATIVE MODELS - FINDING THE RIGHT BALANCE
Chair:  Levick (Basel, Switzerland)
 
10:30-12:00 Meeting Room 212 & 213
SYMPOSIUM: IMMUNOGENICITY MITIGATION STRATEGIES FOR BIOSIMILARS
Chair:  Declerck, P.J. (Leuven, Belgium)
 
10:30-12:00 Meeting Room 219 & 220
APSA SYMPOSIUM: BARRIER MECHANISMS TEAM UP: INTERPLAY BETWEEN TRANSPORTERS, ENZYMES AND TIGHT JUNCTIONS
Chair:  Nicolazzo, J. (Parkville, Australia)
 
10:30-12:00 Meeting Room 210
SYMPOSIUM: NANOTECHNOLOGIES FOR DRUG DELIVERY
Chair:  Guy, R.H. (Bath, United Kingdom)
 
10:30-12:00 Meeting Room 211
SYMPOSIUM: ENABLING PERSONALIZED MEDICINE: GETTING THE FRAMEWORK RIGHT?
Chair:  Sadee, W. (Columbus, United States of America)
 
13:00-14:30 Plenary 3
SYMPOSIUM: DRUG DEVELOPMENT EFFORTS TO COMBAT TROPICAL DISEASES
Chair:  Charman, S. (Parkville, Australia)
 
13:00-14:00 Meeting Room 212 & 213
MINI-SYMPOSIUM: BIOSIMILARS: CHALLENGES AND OPPORTUNITIES
Chair:  Skerritt, J. (, Australia)
 
13:00-14:30 Meeting Room 219 & 220
APSA SYMPOSIUM: INTRACELLULAR DRUG TRAFFICKING AND TARGETING
Chair:  Mclachlan (Sydney, Australia)
 
13:00-14:30 Meeting Room 210
SYMPOSIUM: SAFETY OF NANOMEDICINES: REALITY CHECK?
Chair:  Fricker, G. (Heidelberg, Germany)
 
13:00-14:30 Meeting Room 211
SUBMITTED ORALS
Chair:  Ward (Randwick Nsw, Australia)
 
14:00-15:30 Meeting Room 212 & 213
SUBMITTED ORALS
Chair:  Garg, S. (Adelaide, Australia)
 
14:30-15:30 Plenary 3
FIP KEYNOTE: ACCELERATING DEVELOPMENT FOR CHINA AND BEYOND: PATIENT, SCIENCE, AND PUBLIC HEALTH
Chair:  Wei (, China)
 
14:30-15:30 Meeting Room 219 & 220
SUBMITTED APSA ORALS
Chair:  Ryan (Melbourne, Australia) ; Nassta (Melbourne, Australia)
 
14:30-15:30 Meeting Room 210
SUBMITTED ORALS
Chair:  Sasaki, H. (Nagasaki, Japan)
 
14:30-15:30 Meeting Room 211
KEYNOTE: THERAPEUTIC MONOCLONAL ANTIBODIES: WHERE HAVE WE COME, AND WHERE ARE WE GOING?
Chair:  Morris, Marilyn (, Australia)
 
16:00-17:20 Plenary 3
INDIAN SHOWCASE
Chair:  Midha, K. (, India) ; Barbhaiya, R. (Bangalore, India)
 
16:00-17:30  
Biosimilars - Current topics and controversies
 
16:00-17:30 Meeting Room 219 & 220
APSA EARLY CAREER RESEARCHER SYMPOSIUM
Chair:  Aslani, P. (, Australia)
 
16:00-17:30 Meeting Room 210
SUBMITTED ORALS
Chair:  Anderson, B. (Lexington Kentucky, United States of America)
 
16:00-17:30 Meeting Room 211
SUBMITTED ORALS
Chair:  Williams, D.W. (Adelaide, Australia)
 
16:00-17:30 Meeting Room 212 & 213
ROUND TABLE - INTERCHANGEABILITY OF BIOSIMILARS - YES OR NO?
Chair:  Chamberlain, P. (Leatherhead Surrey, United Kingdom)
 
Wednesday, 16 April 2014
 
07:00-08:00 Meeting Room 219 & 220
SUNRISE SESSION: MEET THE EXPERT
Chair:  Nicolazzo, J. (Parkville, Australia) ; Phan (Melbourne, Australia)
 
07:00-08:00 Meeting Room 210
SUNRISE SESSION: MEET THE EXPERT
Chair:  Pauletti (Cincinnati, United States of America) ; Chekhtman, I. (, Australia)
 
07:00-08:00 Meeting Room 211
SUNRISE SESSION: MEET THE EXPERT
Chair:  Boyd, B. (Parkville, Australia) ; Feeney, O. (Melbourne, Australia)
 
08:00-09:00 Plenary 3
PHARMACEUTICAL SCIENCES 2020 – AN ASIAN PERSPECTIVE
Chair:  Benet, L.Z. (San Francisco, United States of America) ; Hosey (San Francisco, United States of America)
 
09:00-10:00 Plenary 3
FIP KEYNOTE: A GLANCE ON CURRENT PROGRESS OF INNOVATIVE DRUG R&D IN CHINA
Chair:  Tucker, G. (Sheffield, United Kingdom)
 
09:00-10:00 Meeting Room 212 & 213
MINI SYMPOSIUM: MOLECULAR AND FUNCTIONAL IMAGING IN DRUG DEVELOPMENT AND EARLY CLINIC
Chair:  Roberts (Westlake, Australia)
 
09:00-10:00 Meeting Room 219 & 220
DDA KEYNOTE: BLOCK COPOLYMER MICELLES AS SMART NANO CARRIERS FOR TARGETED DRUG DELIVERY
Chair:  Boyd, B. (Parkville, Australia)
 
09:00-10:00 Meeting Room 210
FIP KEYNOTE: A GENOMICS VIEW OF DRUG THERAPY
Chair:  Mckinnon, R.A. (Bedford Park, Australia)
 
09:00-10:00 Meeting Room 211
MINI SYMPOSIUM: DRUG DISCOVERY IN ACADEMIA
Chair:  Nair, P. (Adelaide, Australia)
 
10:30-12:00 Meeting Room 211
SYMPOSIUM: NATURAL PRODUCTS - SUSTAINABLE USE OF MEDICINAL PLANT RESOURCES
Chair:  Ito, M. (Kyoto, Japan)
 
10:30-12:00 Meeting Room 212 & 213
SYMPOSIUM: NEW MOLECULAR AND CELLULAR TARGETS FOR THE TREATMENT OF HUMAN DISEASE
Chair:  Bunnett, N. (Parkville, Australia)
 
10:30-12:00 Meeting Room 219 & 220
DDA SYMPOSIUM: SELF-ASSEMBLED DRUG DELIVERY SYSTEMS
Chair:  Prestidge (Mawson Lakes, Australia)
 
10:30-12:00 Meeting Room 210
SYMPOSIUM: TRANSPORTERS AS MEDIATORS OF CLINICAL DRUG-DRUG INTERACTIONS
Chair:  Elmquist, W.F. (Minneapolis Minnesota, United States of America)
 
10:30-12:00 Meeting Room 219 & 220
SYMPOSIUM: NON-ADHERENCE - THE LARGEST CONTRIBUTION TO VARIABILITY IN DRUG RESPONSE
Chair:  Wiese, M D (Adelaide, Australia)
 
13:00-14:30 Plenary 3
SYMPOSIUM: CROSSING THE BRIDGE – BRIDGING STUDIES
Chair:  Coory, M. (, Australia)
 
13:00-14:00 Meeting Room 212 & 213
FIP KEYNOTE: UNDERSTANDING THE PHYSICOCHEMICAL AND BIOLOGICAL DETERMINANTS OF PHARMACOKINETICS: FROM HUMANS TO ORGANS, CELLS AND NANOSYSTEMS
Chair:  Mager, D. (New York, United States of America)
 
13:00-14:30 Meeting Room 219 & 220
DDA SYMPOSIUM: PULMONARY DRUG DELIVERY
Chair:  Young, P.M. (Sydney, Australia)
 
13:00-14:30 Meeting Room 210
SYMPOSIUM: HERB-DRUG INTERACTIONS: ARE THEY DANGEROUS?
Chair:  Bird, P. (, Australia)
 
13:00-14:15 Meeting Room 211
SUBMITTED ORALS
Chair:  Grainger, D. (Salt Lake City, United States of America)
 
14:00-15:30 Meeting Room 212 & 213
SUBMITTED ORALS
Chair:  Kumamoto, T. (Nihitokyo Tokyo, Japan)
 
14:30-15:30 Plenary 3
FIP KEYNOTE: PHYSICAL PHARMACY AND PHARMACEUTICS, GRAND ACHIEVEMENTS, AND NOW FOR THE FUTURE
Chair:  Anderson, B. (Lexington Kentucky, United States of America)
 
14:30-15:30 Meeting Room 219 & 220
DDA SUBMITTED ORALS
Chair:  Toth, I. (Brisbane, Australia)
 
14:30-15:30 Meeting Room 210
SUBMITTED ORALS
Chair:  Semple, S. (Adelaide, Australia)
 
14:30-15:30 Meeting Room 211
SUBMITTED ORALS
Chair:  Brooks, G. (Reading, United Kingdom)
 
16:00-17:20 Plenary 3
SHOWCASE CHINA
Chair:  Wei (, China) ; Han, S. (Melbourne, Australia)
 
16:00-17:00 Meeting Room 212 & 213
ROUND TABLE: IUPHAR / FIP: TRANSLATION THROUGH COOPERATION – HOW CAN CLINICAL PHARMACOLOGY AND PHARMACEUTICAL SCIENCES WORK TOGETHER MORE EFFECTIVEL
Chair:  Tucker, G. (Sheffield, United Kingdom)
 
16:00-17:30 Meeting Room 210
ROUND TABLE / DEBATE: DOES ALTERED PHYSIOLOGY ALWAYS EQUATE TO ALTERED DRUG DISPOSITION?
Chair:  Brouwer, K. (Chapel Hill North Carolina, United States of America)
 
16:00-17:30 Meeting Room 211
ROUND TABLE / DEBATE
Chair:  Shah (North Potomac Md, United States of America)
 
16:30-18:00 Meeting Room 219 & 220
DDA SUBMITTED ORALS
Chair:  Barnes, T. (Adelaide, Australia)
 
POSTER SESSIONS
17:00-17:30  
Posters A - Analytical Sciences and Pharmaceutical Quality
 
17:00-17:30  
Posters B- Biotechnology (Vaccine)
 
17:00-18:00  
Posters C - Drug Design and Discovery
 
17:00-17:30  
Posters D - Formulation Design and Pharmaceutical Technology
 
17:00-17:30  
Posters E - Natural Products
 
17:00-17:30  
Posters F - Pharmacoepidemiology and Health Technology Assessment
 
17:00-17:30  
Posters G - Pharmacokinetics (PK), Pharmacodynamics (PD) and Systems Pharmacology
 
17:00-17:30  
Posters H - Pharmacology
 
17:00-17:30  
Posters I - Regulatory Sciences
 
17:00-17:30  
Posters J - Translational Research and Individualized Medicines
 
BIOGRAPHIES INVITED SPEAKERS
 
09:00-17:00  
BIOGRAPHIES - INVITED SPEAKERS